Emergent BioSolutions
EBS
#7691
Rank
A$0.56 B
Marketcap
A$10.96
Share price
-6.51%
Change (1 day)
13.84%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): A$0.25 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are A$0.75 Billion. In 2024 the company made an earning of -A$0.11 Billion, an increase over its 2023 earnings that were of -A$0.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.25 B-354.09%
2024 -A$0.11 Billion-88.82%
2023 -A$0.91 Billion242.73%
2022 -A$0.27 Billion-153.8%
2021 A$0.49 B-20.43%
2020 A$0.62 B278.02%
2019 A$0.16 B27.11%
2018 A$0.12 B-27.12%
2017 A$0.17 B17.21%
2016 A$0.15 B0.45%
2015 A$0.15 B73.51%
2014 A$86.71 M41.36%
2013 A$61.34 M35.2%
2012 A$45.37 M0.4%
2011 A$45.19 M-56.46%
2010 A$0.10 B76.73%
2009 A$58.72 M32.94%
2008 A$44.17 M-5.62%
2007 A$46.8 M
2005 A$67.77 M269.89%
2004 A$18.32 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.98 B 6,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.60 B 7,856.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.16 B 5,956.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-A$17.5 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
A$0.12 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.41 Billion-273.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.21 B 1,273.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel